Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danshen and Gegen for Atherosclerosis Prevention in High-Risk Hypertension
NCT01033630Phase 2Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jan 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Danshen Capsule, puerariae lobatae radix in atherosclerosis, sponsored by The Chinese University of Hong Kong. Started Jan 2006; status: completed.
02
Drugs
Danshen Capsulepuerariae lobatae radix
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT01033630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01033630.